In accordance with art. 5.15 of the Regulation on the Federal Service for Surveillance in Healthcare approved by the Decree dated June 30, 2004 № 323 of the Government of the Russian Federation, the powers of Roszdravnadzor include cooperation with governmental authorities of foreign states and international institutions within the specified activities.
In accordance with the signed memorandums and protocols about cooperation for the period since 2010 Roszdravnadzor has established regular cooperation with the China Food and Drug Administration (CFDA), Central Drugs Standard Control Organization of India (CDSCO), Food and Drug Administration of the USA (FDA), U.S. Pharmacopoeia Convention (USP), European Directorate for the Quality of Medicines and Healthcare (EDQM), Medicines and Medical Devices Agency of Serbia (ALIMS), State Administration of Ukraine on Medicinal Products, State Expert Center of the Ministry of Health of Ukraine, Ministry of Health of the Republic of Belarus, National Center for Medicines, Medical Devices and Medical Equipment Expertise of Kazakhstan, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Global Medical Device Nomenclature (GMDN) and has exercised its membership in the International Medical Device Regulators Forum (IMDRF).
In accordance with provisions of the memorandums and protocols the parties exchange information relating to of quality, efficacy and safety of medical products, share their experience, best methods and practices during training courses, seminars and conferences, learn the experience of their foreign regulatory bodies, effecting control and supervision over medical products, collaborate on developing and implementing of international measures against circulation of counterfeit and substandard medical products.
Specialists of Roszdravnadzor participate in activities of the following work and expert groups:
- World Health Organization (WHO)
- Black Sea Economic Cooperation (BSEC)
- Organization for Economic Cooperation and Development (OECD)
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), etc